NEOD.ST
Price:
$0.9
Market Cap:
$29.35M
NeoDynamics AB (publ), a medical technology company, develops biopsy system to enhance diagnosis and care of breast cancer patients. It develops NeoNavia, a precision biopsy system that offers clinicians and patients accurate lesion targeting and high tissue yield for correct diagnosis and individualized treatment. The company was incorporated in 2015 and is based in Lidingö, Sweden.
Industry
Medical - Devices
IPO Date
2018-12-07
Stock Exchange
STO
Ticker
NEOD.ST
According to NeoDynamics AB (publ)’s latest financial reports and current stock price. The company's current ROE is -82.80%. This represents a change of 66.73% compared to the average of -49.66% of the last 4 quarters.
The mean historical ROE of NeoDynamics AB (publ) over the last ten years is -70.09%. The current -82.80% ROE has changed 18.13% with respect to the historical average. Over the past ten years (40 quarters), NEOD.ST's ROE was at its highest in in the March 2018 quarter at 0%. The ROE was at its lowest in in the June 2023 quarter at -73.68%.
Average
-70.09%
Median
-35.12%
Minimum
-225.45%
Maximum
-19.34%
Discovering the peaks and valleys of NeoDynamics AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 262.96%
Maximum Annual ROE = -19.34%
Minimum Annual Increase = -44.94%
Minimum Annual ROE = -225.45%
Year | ROE | Change |
---|---|---|
2023 | -225.45% | 155.87% |
2022 | -88.11% | 25.53% |
2021 | -70.19% | 262.96% |
2020 | -19.34% | -44.94% |
2019 | -35.12% | 43.90% |
2018 | -24.41% | -12.82% |
The current ROE of NeoDynamics AB (publ) (NEOD.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-127.91%
5-year avg
-87.64%
10-year avg
-70.09%
NeoDynamics AB (publ)’s ROE is less than Duearity AB (publ) (289.50%), greater than Oncopeptides AB (publ) (-294.46%), greater than IRRAS AB (publ) (-129.31%), greater than Abliva AB (publ) (-133.42%), greater than Episurf Medical AB (publ) (-77.80%),
Company | ROE | Market cap |
---|---|---|
289.50% | $3.08M | |
-294.46% | $771.11M | |
-129.31% | $181.75M | |
-133.42% | $715.67M | |
-77.80% | $37.72M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoDynamics AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeoDynamics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NeoDynamics AB (publ)'s ROE?
How is the ROE calculated for NeoDynamics AB (publ) (NEOD.ST)?
What is the highest ROE for NeoDynamics AB (publ) (NEOD.ST)?
What is the 3-year average ROE for NeoDynamics AB (publ) (NEOD.ST)?
What is the 5-year average ROE for NeoDynamics AB (publ) (NEOD.ST)?
How does the current ROE for NeoDynamics AB (publ) (NEOD.ST) compare to its historical average?